FGFR2-IIIc isoform detection reveals prognostic prevalence and a functional link to mesenchymal transition in gastric and gastroesophageal junction cancer.

ESMO Open · 2025 · PMC12615283 · PMID 41172570

Europe PMC DOI

hedged sentence

0.2400

closest p · 4.8× alpha

0.2400

boldest claim

The sentences

did not reach statistical significanceP = 0.24not close (p > 0.1)

While molecular targeted agent-containing regimens showed numerically higher rates of FGFR2-IIIc increase compared with other treatments, this difference did not reach statistical significance ( P = 0.24).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.